Author: Detrick, Barbara; Lee, Maria Teresa; Chin, Marian S.; Hooper, Laura C.; Chan, Chi-Chao; Hooks, John J.
Title: Experimental coronavirus retinopathy (ECOR): Retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection Cord-id: 0xhn1lqg Document date: 2008_1_1
ID: 0xhn1lqg
Snippet: Mouse hepatitis virus induces a biphasic disease in BALB/c mice that consists of an acute retinitis followed by progression to a chronic retinal degeneration with autoimmune reactivity. Retinal degeneration resistant CD-1 mice do not develop the late phase. What host factors contribute to the distinct responses to the virus are unknown. Herein, we show that IFN-α, IFN-β and IFN-γ act in concert as part of the innate immune response to the retinal infection. At day 2, high serum levels of IFN-
Document: Mouse hepatitis virus induces a biphasic disease in BALB/c mice that consists of an acute retinitis followed by progression to a chronic retinal degeneration with autoimmune reactivity. Retinal degeneration resistant CD-1 mice do not develop the late phase. What host factors contribute to the distinct responses to the virus are unknown. Herein, we show that IFN-α, IFN-β and IFN-γ act in concert as part of the innate immune response to the retinal infection. At day 2, high serum levels of IFN-γ, CXCL9 and CXCL10, were detected in BALB/c mice. Moreover, elevated levels of CXCL9 and CXCL10 gene expression were detected in retinal tissue. Although IFN-γ and the chemokines were detected in CD-1 mice, they were at significantly lower levels compared to BALB/c mice. These augmented innate responses observed correlated with the development of autoimmune reactivity and retinal degeneration and thus may contribute to the pathogenic processes.
Search related documents:
Co phrase search for related documents- accordingly report and acute infection result: 1
- acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- acute infection and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute infection and adequate protection: 1, 2, 3, 4, 5, 6, 7
- acute infection and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- acute infection and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute infection and liver express: 1, 2
- acute infection and liver specific: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute infection and localized expression: 1
- acute infection and low standard: 1, 2, 3, 4
- acute infection and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute infection result and liver damage: 1
- acute infection result and liver disease: 1
- acute phase and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8
- acute phase and additional study: 1, 2
- acute phase and adequate protection: 1
- acute phase and liver damage: 1, 2, 3, 4, 5, 6
- acute phase and liver disease: 1, 2, 3, 4, 5, 6
- acute phase and liver express: 1
Co phrase search for related documents, hyperlinks ordered by date